Jason W Denbo1, Liang Zhu2, DeoKumar Srivastava2, Dennis C Stokes3, Saumini Srinivasan3, Melissa M Hudson4, Kirsten K Ness5, Leslie L Robison5, Michael Neel6, Bhaskar Rao6, Fariba Navid4, Andrew M Davidoff6, Daniel M Green5. 1. Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN. Electronic address: jdenbo@uthsc.edu. 2. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN. 3. Department of Pediatrics, University of Tennessee Health Science Center, and Program in Pediatric Pulmonary Medicine Le Bonheur Children's Hospital-St. Jude Children's Research Hospital, Memphis, TN. 4. Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN. 5. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN. 6. Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN.
Abstract
BACKGROUND: Complete resection of lung metastases improves survival in patients with osteosarcoma. We evaluated the long-term effect of metastasectomy on pulmonary function of patients treated for osteosarcoma during childhood. STUDY DESIGN: We reviewed the medical records of patients who had pulmonary function tests (PFTs) after metastasectomy for osteosarcoma. Patient, tumor, and treatment variables were abstracted along with PFTs. The PFTs were recorded as a percentage of predicted value and were classified as abnormal for forced vital capacity (FVC) < 80%, forced expiratory volume in 1 second (FEV1) < 80%, total lung capacity (TLC) < 75%, and single breath diffusion capacity for carbon monoxide corrected for hemoglobin (DLCOcorr) < 75%. RESULTS: Twenty-one patients had PFTs performed during follow-up. Mean age at diagnosis of osteosarcoma was 13.2 ± 4.7 years (SD). Fifteen patients had a single thoracotomy, and 6 patients had ≥2 thoracotomies (range 2 to 6). Eighty lesions were resected. Nine patients had ≤2 lesions resected and 12 patients had >2 lesions (range 3 to 12) resected. Mean time from the last surgical procedure to measurement of PFTs was 20.3 ± 9.0 years (SD). Total lung capacity was abnormal for 28.6%, DLCOcorr for 47.4%, FVC for 40%, and FEV1 for 47.6% of the cohort members. Individual PFTs were abnormal in 13.3% (TLC) to 46.7% (DLCOcorr) of patients who had 1 thoracotomy and in 50.0% (DLCOcorr) to 66.7% (FEV1, TLC) of patients with ≥2 thoracotomies. The number of thoracotomies was associated with abnormal TLC (p = 0.03). CONCLUSIONS: Patients who underwent pulmonary metastasectomy for osteosarcoma as children often had abnormal PFTs on long-term follow-up, but the reduction in lung volumes and DLCOcorr was relatively mild. Multiple thoracotomies predicted greater impairment of pulmonary function.
BACKGROUND: Complete resection of lung metastases improves survival in patients with osteosarcoma. We evaluated the long-term effect of metastasectomy on pulmonary function of patients treated for osteosarcoma during childhood. STUDY DESIGN: We reviewed the medical records of patients who had pulmonary function tests (PFTs) after metastasectomy for osteosarcoma. Patient, tumor, and treatment variables were abstracted along with PFTs. The PFTs were recorded as a percentage of predicted value and were classified as abnormal for forced vital capacity (FVC) < 80%, forced expiratory volume in 1 second (FEV1) < 80%, total lung capacity (TLC) < 75%, and single breath diffusion capacity for carbon monoxide corrected for hemoglobin (DLCOcorr) < 75%. RESULTS: Twenty-one patients had PFTs performed during follow-up. Mean age at diagnosis of osteosarcoma was 13.2 ± 4.7 years (SD). Fifteen patients had a single thoracotomy, and 6 patients had ≥2 thoracotomies (range 2 to 6). Eighty lesions were resected. Nine patients had ≤2 lesions resected and 12 patients had >2 lesions (range 3 to 12) resected. Mean time from the last surgical procedure to measurement of PFTs was 20.3 ± 9.0 years (SD). Total lung capacity was abnormal for 28.6%, DLCOcorr for 47.4%, FVC for 40%, and FEV1 for 47.6% of the cohort members. Individual PFTs were abnormal in 13.3% (TLC) to 46.7% (DLCOcorr) of patients who had 1 thoracotomy and in 50.0% (DLCOcorr) to 66.7% (FEV1, TLC) of patients with ≥2 thoracotomies. The number of thoracotomies was associated with abnormal TLC (p = 0.03). CONCLUSIONS:Patients who underwent pulmonary metastasectomy for osteosarcoma as children often had abnormal PFTs on long-term follow-up, but the reduction in lung volumes and DLCOcorr was relatively mild. Multiple thoracotomies predicted greater impairment of pulmonary function.
Authors: C Nakajima; C Kijimoto; Y Yokoyama; T Miyakawa; Y Tsuchiya; T Kuroda; M Nakano; M Saeki Journal: Pediatr Surg Int Date: 1998-07 Impact factor: 1.827
Authors: Melissa M Hudson; Kirsten K Ness; Vikki G Nolan; Gregory T Armstrong; Daniel M Green; E Brannon Morris; Sheri L Spunt; Monika L Metzger; Kevin R Krull; James L Klosky; Deo Kumar Srivastava; Leslie L Robison Journal: Pediatr Blood Cancer Date: 2010-12-15 Impact factor: 3.167
Authors: James P Butler; Stephen H Loring; Samuel Patz; Akira Tsuda; Dmitriy A Yablonskiy; Steven J Mentzer Journal: N Engl J Med Date: 2012-07-19 Impact factor: 91.245
Authors: Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski Journal: Am J Respir Crit Care Med Date: 2007-05-16 Impact factor: 21.405
Authors: Rodrigo B Interiano; Sue C Kaste; Chenghong Li; Deo Kumar Srivastava; Bhaskar N Rao; William C Warner; Daniel M Green; Matthew J Krasin; Leslie L Robison; Andrew M Davidoff; Melissa M Hudson; Israel Fernandez-Pineda; Kirsten K Ness Journal: J Cancer Surviv Date: 2017-07-01 Impact factor: 4.442
Authors: Samah Hayek; Todd M Gibson; Wendy M Leisenring; Jennifer L Guida; Maria Monica Gramatges; Philip J Lupo; Rebecca M Howell; Kevin C Oeffinger; Smita Bhatia; Kim Edelstein; Melissa M Hudson; Leslie L Robison; Paul C Nathan; Yutaka Yasui; Kevin R Krull; Gregory T Armstrong; Kirsten K Ness Journal: J Clin Oncol Date: 2019-12-04 Impact factor: 44.544
Authors: Israel Fernandez-Pineda; M M Hudson; A S Pappo; M W Bishop; J L Klosky; T M Brinkman; D K Srivastava; M D Neel; B N Rao; A M Davidoff; K R Krull; D A Mulrooney; L L Robison; K K Ness Journal: J Cancer Surviv Date: 2016-06-04 Impact factor: 4.442